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Podocyte injury elicits loss and recovery  
of cellular forces
Kathryn E. Haley1,2*, Nils M. Kronenberg2,3*, Philipp Liehm2,3, Mustafa Elshani1,2,  
Cameron Bell1, David J. Harrison1,2, Malte C. Gather2,3†, Paul A. Reynolds1,2†
In the healthy kidney, specialized cells called podocytes form a sophisticated blood filtration apparatus that allows 
excretion of wastes and excess fluid from the blood while preventing loss of proteins such as albumin. To operate 
effectively, this filter is under substantial hydrostatic mechanical pressure. Given their function, it is expected that 
the ability to apply mechanical force is crucial to the survival of podocytes. However, to date, podocyte mechano-
biology remains poorly understood, largely because of a lack of experimental data on the forces involved. We 
perform quantitative, continuous, nondisruptive, and high-resolution measurements of the forces exerted by dif-
ferentiated podocytes in real time using a recently introduced functional imaging modality for continuous force 
mapping. Using an accepted model for podocyte injury, we find that injured podocytes experience near-complete 
loss of cellular force transmission but that this loss of force is reversible under certain conditions. The observed 
changes in force correlate with F-actin rearrangement and reduced expression of podocyte-specific proteins. By 
introducing robust and high-throughput mechanical phenotyping and by demonstrating the significance of me-
chanical forces in podocyte injury, this research paves the way to a new level of understanding of the kidney. In 
addition, in an advance over established force mapping techniques, we integrate cellular force measurements 
with immunofluorescence and perform continuous long-term force measurements of a cell population. Hence, 
our approach has general applicability to a wide range of biomedical questions involving mechanical forces.
INTRODUCTION
Podocytes serve as the final barrier to protein loss in the kidney 
during filtration of blood by the glomerulus in vivo. Hence, the 
podocyte plays an integral role in maintaining the glomerular filtra-
tion barrier and preventing protein loss into the urine. Podocyte 
damage is now recognized as a causal factor in the progression of 
multiple variants of kidney disease (1–7). While podocyte adapta-
tion to stress is characterized by cell enlargement and shape remod-
eling (hypertrophy and foot process effacement) both in vitro (8, 9) 
and in vivo (10–12), the mechanisms underlying the pathogenesis 
of podocyte injury still remain largely unknown. Systemic and in-
traglomerular hypertension are known effectors of podocyte injury 
in vivo (13–20). A direct correlation has been demonstrated between 
systemic hypertension and concomitant incidence of podocyte 
depletion (21). Increased fluid shear stress and axial capillary wall 
stress resulting from glomerular hypertension further challenge the 
podocyte to adapt to increased mechanical stresses, often resulting in 
podocyte detachment (22). Although multiple studies have demon-
strated the adaptive stress response of podocytes, wherein cyto-
skeletal structure is rearranged to increase foot process length while 
maintaining structural stability of the cell body (1, 2, 8, 23), the ef-
fects of these structural changes on podocyte mechanobiology re-
main largely unknown.
The direct correlation between podocyte depletion and the pro-
gression of glomerular disease has been elegantly illustrated by 
Wharram et al. (6). In a genetically engineered rat model of podo-
cyte depletion, Wharram et al. observed transient proteinuria and 
mesangial sclerosis occurring with 20% podocyte depletion, which 
progressed to sustained proteinuria and global glomerulosclerosis 
with podocyte depletion of more than 40% (6). Evidence of detached, 
viable podocytes shed into the urine of patients with diabetic nephrop-
athy (24), immunoglobulin A nephropathy (3), and focal segmental 
glomerulosclerosis (25, 26) suggests that impaired podocyte adhe-
sion to the glomerular basement membrane (GBM) may be a pivot-
al step in the development of glomerulosclerosis. However, to date, 
there have been limited investigations of the mechanical forces that 
podocytes apply to their substrate and of the effect of injury on podo-
cyte cellular forces in vitro. This deficiency is, in part, due to a lack 
of suitable experimental techniques for long-term time-lapse map-
ping of cellular forces.
Elastic resonator interference stress microscopy (ERISM) is a re-
cently developed functional imaging modality for the mapping of 
cellular forces; this technique allows continuous monitoring of me-
chanical cell-substrate interactions for up to several weeks in one 
experiment, which is impossible or impractical with most estab-
lished force microscopy methods (27). ERISM uses an elastic, optical 
microcavity as a cell substrate and images cell-induced substrate dis-
placement with nanometer sensitivity by measuring spectral shifts 
of resonant modes formed inside the microcavity. These displace-
ments are converted into a high-resolution stress map that resolves 
the focal forces the cell applies to the substrate in different locations. 
ERISM enables recording of the mechanical activity of cells without 
acquiring zero- force reference images, eliminating the need to detach 
cells after a measurement. ERISM therefore drastically simplifies in-
vestigation of large numbers of cells on a common substrate and at 
multiple time points. The microcavity substrates used for ERISM show 
excellent long-term stability under mechanical stress and standard 
cell culture conditions, and the optical readout only requires low light 
intensity, therefore preventing phototoxicity and cell damage. These 
properties render ERISM particularly well suited for measuring cel-
lular forces over prolonged periods.
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Here, we characterized cellular force of both differentiated human 
and mouse podocytes using ERISM and investigated alterations in 
podocyte mechanical force during stress response in a puromycin 
aminonucleoside (PAN) model of glomerular injury in vitro. Our 
findings demonstrate that dynamic changes in podocyte cellular 
forces occur in response to acute injury, and further elucidate the 
role of podocyte force transmission in the progression of glomerular 
disease.
RESULTS
Mapping the force transmission phenotype of  
differentiated podocytes
To characterize the force transmission phenotype of differentiated 
human podocytes, we first assessed the differentiation characteristics 
of human podocytes in vitro. We used LY human podocytes (a gift 
from M. Saleem) that contained human telomerase reverse transcrip-
tase (hTERT) and a temperature-sensitive SV40 transgene (28). The 
podocytes were initially cultured in vitro at the permissive tempera-
ture of 33°C and then differentiated over the course of 12 days at the 
nonpermissive temperature of 37°C. Differentiated podocytes demon-
strated increased cell size and finger-like foot process extensions, as 
evidenced by phase-contrast microscopy (Fig. 1A). Ultrastructure of 
differentiated cells was assessed using scanning electron microscopy, 
which revealed both primary and secondary foot process extensions 
branching from the cell body of podocytes (Fig. 1B). We further 
assessed differentiated cells for expression and localization of the 
podocyte slit diaphragm proteins nephrin (NPHS1), podocin (NPHS2), 
and CD2-associated protein (CD2AP) and the foot process protein 
synaptopodin (SYNPO). Immunofluorescence analysis demonstrated 
increased distribution of expression of podocyte-specific proteins in 
differentiated cells compared to proliferating cells (Fig. 1, C and D).
Having established the human LY podocyte cell line as a model 
system of healthy differentiated cells in vitro, we then characterized 
the evolution of cellular forces transmitted by LY podocytes during 
differentiation on a type IV collagen–coated elastic ERISM substrate 
with an apparent stiffness of 6.8 kPa (29), similar to the stiffness of the 
GBM. Figure 2A shows a representative example of phase-contrast 
and ERISM maps recorded over a 12-day differentiation time course. 
By day 5 of differentiation, LY podocytes demonstrated increased 
substrate displacement, indicating increased cellular forces. To quan-
tify podocyte cellular forces and confirm statistical significance, we 
recorded ERISM maps for n > 15 cells at days 1, 5, 8, and 12 of dif-
ferentiation. Taking the total volume by which each cell indents the 
substrate as a proxy for the overall force applied by the cell, a nearly 
fivefold increase in median force was observed (indented volume, 
82 m3 on day 1 versus 380 m3 on day 5; P < 0.0001; Fig. 2B). The 
increase in force was accompanied by a statistically significant, but 
less pronounced, increase in median cell area (1800 m2 on day 1 
versus 4300 m2 on day 5; P < 0.001; Fig. 2C). Between days 6 and 
12 of differentiation, the exerted force did not increase further, and 
the average cell area reduced slightly. However, the pattern of force 
Fig. 1. Differentiation of LY podocytes. (A) Phase-contrast microscopy of proliferating LY human podocytes cultured at 33°C. Differentiation of LY podocytes at 37°C for 
12 days results in a transition to differentiated morphology. Differentiated cells increase in size up to lengths of 150 m and develop finger-like foot processes around the 
periphery of the cell. Scale bar, 50 m. (B) Scanning electron microscopy reveals ultrastructures of primary and secondary foot processes on differentiated LY podocytes. 
(I) LY podocyte differentiated at 37°C for 12 days demonstrates primary foot processes around the cell periphery and extending toward adjacent cell. Scale bar, 20 m. 
(II) Primary foot processes interdigitating between differentiated LY podocytes. Scale bar, 5 m. (III) Primary foot processes branching off of a differentiated LY podocyte. Scale 
bar, 5 m. (IV) Secondary foot processes around the outer periphery of a differentiated podocyte. Scale bar, 10 m. (C) Localization and expression of podocyte- specific 
proteins NPHS1, NPHS2, CD2AP, and SYNPO (red) in proliferating and differentiated LY podocytes assessed by immunocytochemistry at low magnification. DAPI 
(4′,6- diamidino-2-phenylindole) (blue) detects nuclei. Scale bar, 200 m. (D) Localization and expression of podocyte-specific proteins NPHS1, NPHS2, CD2AP, and SYNPO 
(red) in a single differentiated LY podocyte. DAPI (blue) detects nuclei. Scale bar, 50 m; right panels, magnification of area marked by white boxes.
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exertion changed, and an increased number of focal pulling sites 
were formed at the cell periphery (Fig. 2A). To more clearly visualize 
force exertion patterns, the broad features from the displacement 
maps were removed through spatial Fourier filtering of components 
with spatial frequencies smaller than 0.25 m−1 (Fig. 2A, bottom). 
This approach revealed focal pulling points (shown in red on the false 
color map) at the periphery of the cell that were accompanied by focal 
pushing points (in blue) to their proximal side, that is, a character-
istic pull-push twist pattern. Force patterns and the development of 
forces during differentiation were similar in both clusters of cells and 
single cells, with both conditions displaying a pull-push pattern. 
However, in addition, cells seeded on the ERISM substrate at high 
cell density partly overlap each other, resulting in complex force 
patterns (fig. S1). Cells that were differentiated on ERISM substrates 
showed characteristic expression of podocyte-specific proteins (fig. S2).
To determine whether similar force patterns occur in podocytes 
from other model systems, we analyzed cellular forces during the dif-
ferentiation of mouse podocytes, using again a temperature-sensitive 
SV40 transgene to induce differentiation (30). By day 12 of differen-
tiation, mouse podocytes demonstrated increased substrate displace-
ment and a nearly fivefold increase in median force (P < 0.0001; fig. S3). 
The successful differentiation of mouse podocytes was again verified 
by immunofluorescence for podocyte slit diaphragm and foot pro-
cess proteins (fig. S4).
Immunostaining of differentiated LY podocytes on the ERISM 
substrate for F-actin, vinculin, and CD2AP revealed a high concen-
tration of vinculin—a protein known to assemble at focal adhesion 
contacts and in the foot processes of podocytes—at the periphery of 
the cell and in the center between the pushing and pulling points 
seen in Fourier-filtered ERISM maps (Fig. 3). Immunostaining for 
1 integrin revealed colocalization with vinculin and with ERISM 
maps (fig. S5). These data suggest that the twisting originates from 
a torque that the contractile forces exerted by the cell induce at the 
contact points with the substrate as they pull F-actin fibers toward 
the center of the cell. The number of pull-push twist features in-
creased during the differentiation process, and by day 12, they oc-
curred around the entire periphery of differentiated LY podocytes. 
Similar to LY podocytes, the number of pull-push twist features also 
increased in mouse podocytes during the differentiation process, and 
by day 12, twist features occurred around the periphery of differen-
tiated podocytes (fig. S3). Collectively, these findings demonstrate 
that ERISM can be used to distinguish and quantify dynamic forces 
exerted by podocytes during differentiation in vitro.
Podocyte stress response is reversible in an in vitro  
PAN injury model
In light of recent findings that detached podocytes in glomerular 
disease remain viable (24, 31), we hypothesized that acute injury to 
podocytes by PAN would interfere with the mechanics of cell adhe-
sion but may be reversible. Following 24 hours of PAN treatment, a 
reduced expression area of podocyte-specific proteins NPHS1, NPHS2, 
CD2AP, and SYNPO was observed (Fig. 4). Immunofluorescence 
analysis revealed a loss of focal, punctate staining of both CD2AP 
and SYNPO, suggesting a loss of slit diaphragm and foot process 
architecture. Moreover, PAN treatment resulted in rounded cell 
morphology, with loss of finger-like foot process extensions around 
Fig. 2. Mapping mechanical force exerted by human podocytes throughout differentiation. (A) Representative phase-contrast images (upper row), ERISM displace-
ment maps (middle row), and Fourier-filtered ERISM maps (lower row) taken at different time points during the 12-day differentiation of LY podocytes. (B and C) Tukey 
boxplots of (B) mechanical activity and (C) cell area during LY podocyte differentiation. Each dot represents one cell. As data in groups were not normally distributed, 
groups were compared using the Mann-Whitney U test (n.s., no significance; *P < 0.05; ***P < 0.001; ****P < 0.0001). Scale bars, 50 m.
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the cell periphery, and decreased cell size for some cells. Washout of 
PAN and return to differentiation medium resulted in a partial recov-
ery of the localization and expression of NPHS1, NPHS2, CD2AP, 
and SYNPO 5 days after washout. In particular, a return of punctate 
CD2AP and NPHS1 staining was observed around the cell periphery. 
Differentiated cell morphology recovered partially, as evidenced by 
the return of finger-like foot process extensions (Fig. 4). In addi-
tion, F-actin immunostaining showed rearrangement and bundling 
of F-actin in PAN-treated podocytes, which also partially recovered 
following washout, as evidenced by a return of striated F-actin 
staining (Fig. 4). Together, these findings suggest that podocyte vi-
ability is maintained in some cells following an initial response to 
acute injury in vitro.
PAN treatment leads to loss of mechanical  
force in podocytes
Next, we asked whether PAN injury was concomitant with a loss of 
podocyte cellular forces. During PAN treatment, podocyte cellular 
forces were monitored continuously using ERISM. An initial 
increase in force was observed 4 to 5 hours after the addition 
of PAN [indented volume, 590 (± 150) m3 at 0 hours versus 1370 
(± 350) m3 at 4 hours; P = 0.03; Fig. 5, A and B, and video S1]. 
Decreased podocyte forces were then observed 6.5 hours after the 
addition of PAN, with a further decrease until 10 to 16 hours after 
the addition of PAN, when minimal force was detected [indented 
volume, 130 (± 70) m3] and the push-pull patterns at the periphery 
of the cells disappeared (forces before PAN treatment versus forces 
at the end of PAN treatment, P = 0.03; peak forces during PAN 
treatment versus forces at the end of PAN treatment, P = 0.03; 
Fig. 5A). In the absence of PAN treatment, LY podocyte forces 
oscillated by only 15% (±9% SD; n = 7).
Despite the loss in force, phase-contrast microscopy showed con-
tinued cell attachment, even after 16 hours of PAN treatment. Con-
sistent with other observations of podocyte adaptation to stress both 
in vitro and in vivo (8, 9), there was an increase in cell area from an 
average of 3000 (± 1300) m2 at the onset of PAN treatment to an 
average of 8000 (± 4900) m2 at 16 hours after PAN addition for 
three of the four tracked cells (Fig. 5D).
Comparing ERISM and immunofluorescence maps after PAN 
treatment, we find that podocytes still showed localized vinculin ex-
pression, albeit at a reduced level, which explains their ability to 
adhere to the substrate. However, depending on PAN concentra-
tion, the actin cytoskeleton was largely impaired, and only minimal 
force was detected (fig. S6).
Together, these findings demonstrate that LY podocytes respond 
to PAN by a near-complete loss of force despite the increase in cell 
area and the fact that they remain attached to the substrate. This 
suggests that cell force transmission and cell attachment are separable 
phenotypes under these conditions.
Similarly, mouse podocyte forces showed an initial increase 1 to 
4 hours after the addition of PAN (P = 0.04; fig. S7 and video S3). 
After the 6-hour PAN time point, podocyte forces decreased until 9 
to 11 hours after PAN addition, when minimal force was detected 
and the push-pull patterns at the periphery of the cells disappeared 
(forces before PAN treatment versus forces at the end of PAN treat-
ment, P = 0.004; peak forces during PAN treatment versus forces at 
the end of PAN treatment, P = 0.004; fig. S7). Again, forces oscillated 
by only 20% before PAN treatment (±10% SD; n = 6). Despite the 
loss of force, phase- contrast microscopy showed continued cell 
attachment, even after 11 hours of PAN treatment (fig. S7).
Podocytes recover force transmission  
following PAN washout
Because podocytes demonstrated partial recovery of localization 
and expression of NPHS1, NPHS2, CD2AP, and SYNPO after PAN 
washout, we hypothesized that cellular forces could also be recov-
ered following PAN washout. During PAN washout, partial recov-
ery of podocyte cellular force transmission was observed within the 
first 24 hours of washout (Fig. 5, B and C, and video S2). The onset 
of force recovery occurred at 10 hours after PAN washout for three 
of the four investigated cells, while one cell died during PAN wash-
out. Twenty hours after washout, podocyte forces had recovered to 
Fig. 3. Contractile podocyte forces are colocalized with vinculin expression. (A) Phase-contrast image and (B) ERISM displacement map generated by a fully differen-
tiated podocyte (day 12). (C) Epifluorescence image of the same cell following fixation and immunostaining for actin, vinculin, CD2AP, and nuclear DNA. (D) Fourier- 
filtered ERISM map, with black lines indicating vinculin-rich areas. Scale bar, 50 m. (E) Magnification of the area highlighted in (D). Scale bar, 10 m.
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the level of forces exerted by differentiated cells before PAN treat-
ment in two of the four investigated cells, and the pull-push twist 
patterns at the periphery of the cells returned (Fig. 5C). In contrast, 
the average cell area did not change significantly in the three cells 
tracked during PAN washout [4000 (± 2700) m2 at start of wash-
out and 4900 (± 4300) m2 after washout; Fig. 5D]. Forces remained 
stable and at levels comparable to non–PAN-treated differentiated 
cells for 3 days after the PAN washout (fig. S8).
A similar partial recovery of cellular forces was observed for 
mouse podocytes within the first 24 hours following PAN wash-
out (fig. S7 and video S4). The onset of force recovery occurred at 
10 hours after PAN washout for four of the six investigated cells, 
while two cells died during PAN washout. By 24 hours after wash-
out, podocyte forces of the viable cells had recovered to the level of 
forces exerted by differentiated cells before PAN treatment, and the 
characteristic pull-push twist patterns at the periphery of the cells 
returned (fig. S7). Collectively, these findings demonstrate that podo-
cyte force transmission recovers after acute injury within 24 hours 
of washout in vitro.
DISCUSSION
Using the ERISM assay on both human and mouse podocytes, we 
demonstrate continuous monitoring of podocyte cellular forces at 
high spatial resolution over an extended 17-day time course. ERISM 
imaging demonstrated contractile forces exerted at localized contact 
points predominantly around the cell periphery of differentiated 
podocytes. PAN treatment resulted in membrane blebbing and foot 
process effacement, as evidenced by F-actin rearrangement and a 
reduced expression pattern of NPHS1, NPHS2, CD2AP, and SYNPO. 
PAN treatment also resulted in an initial increase in podocyte cellular 
forces of up to twofold the original value, followed by a complete 
loss of cellular force, despite continued cell attachment. Following 
PAN washout, partial recovery of podocyte force transmission was 
observed. These findings have important implications for the 
mechanobiology of podocyte detachment.
The role of mechanical forces in the progression of glomerular 
disease has previously been explored in the context of systemic and 
intraglomerular hypertension (13–20). Intrarenal hypertension and 
hyperfiltration have long been correlated with glomerular injury 
(16, 17, 19). Anderson et al. (13) were able to show that control of 
glomerular hypertension limits glomerular injury, findings that 
were further supported by the hyperfiltration theory published by 
Brenner et al. (14), in which control of glomerular pressure was 
highlighted as a hallmark for the prevention of glomerular disease. 
However, until recently, the mechanism underlying the role of hy-
pertension in glomerular disease progression remained largely un-
known. In a timely review on the role of mechanical forces in the 
detachment of podocytes, Kriz and Lemley (22) hypothesize that 
detachment of viable podocytes may result from exposure to me-
chanical distention of the GBM or from fluid shear forces, both re-
sulting in impaired cellular adhesion. In further explaining the role 
of mechanical forces in podocyte detachment, Endlich et al. (32) 
highlight P2X4 and TRPC6 as potential mechanosensor proteins 
responsible for mechanosignaling in podocytes as well as the mech-
anosensor talin, which binds both actin and integrins. The authors 
note that, in single- molecule experiments, talin unfolding results 
from piconewton forces and this exposes binding sites for vinculin 
(32). Therefore, through talin, vinculin serves as an important actin- 
integrin connection. It is thus reasonable to suggest that cyto-
skeletal rearrangement resulting from glomerular hypertension or 
hypertrophy may initiate a signaling cascade, resulting in loss of 
31 integrin cell contacts with the GBM and subsequent podocyte 
detachment.
Vogelmann et al. (26) suggest that detached podocytes in glo-
merular disease are viable and that detachment may be initiated by 
physiological factors rather than intrinsic podocyte dysregulation. 
While this hypothesis is supported by numerous studies (24, 31, 33), 
Fig. 4. Reduced expression of podocyte-specific proteins in a PAN injury model is reversible in vitro. Localization and expression of podocyte-specific proteins 
NPHS1, NPHS2, CD2AP, and SYNPO (red) and F-actin (green) in differentiated, PAN (25 g/ml)–treated LY podocytes and 5-day PAN washout of LY podocytes assessed by 
immunocytochemistry. DAPI (blue) detects nuclei. Scale bar, 50 m.
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it raises the question of the origin of the variability between podo-
cytes that accounts for the detachment of some cells but not others. 
Hostetter et al. (16) suggest that podocyte stress response mecha-
nisms may occur through a common pathway, independent of 
the etiology of the original glomerular injury. On the basis of our 
findings, we hypothesize that the ability of podocytes to maintain 
or recover cellular force transmission may be central to preventing 
detachment.
Despite recent advances in our ability to study podocyte detach-
ment through urinary podocin mRNA/creatinine ratios (34, 35), our 
current understanding of podocyte detachment in glomerular disease 
is otherwise limited to histopathological observation (36, 37) and 
statistical modeling (38). Cho et al. (38) present a quantitative podo-
cyte detachment hypothesis based on the Ising statistical mechanics 
model that uses Monte Carlo simulations to predict cell attachment 
under both normal and disease conditions in the glomerulus. We 
speculate that any condition that results in podocyte injury (that is, 
changes to the actin cytoskeleton and foot processes) would elicit 
changes in the pattern of forces applied by podocytes to their sub-
strate. In a clinical setting, we hypothesize that these conditions could 
include hypertension, diabetic nephropathy, transplant/obesity- 
related glomerular hypertrophy, or postnephrectomy-related renal 
changes. In our in vitro experiments using PAN, we find that there 
is a window of opportunity for recovery within about 24 hours of 
PAN treatment. Although the physiology in a human kidney is more 
complex and the extent of clinical damage likely depends on the timing 
and extent of sustained injury, a similar window of opportunity for 
recovery may exist in vivo. A clinical example of recovery from podo-
cyte damage is minimal change disease (MCD), in which podocytes 
remain attached but could exhibit reduced cellular forces. Patients with 
MCD present with proteinuria but respond well to corticosteroid 
therapy, in many cases leading to complete remission (39).
In conclusion, we investigate here the role of podocyte cellular 
forces and the underlying mechanobiology preceding podocyte de-
tachment in real time. We show that (i) mechanical forces increase 
upon differentiation of podocytes, (ii) contractile podocyte forces 
are transmitted via specific contact points formed in vinculin-rich 
regions, and (iii) podocyte force transmission is recovered following 
PAN treatment and washout. On the basis of our investigation of the 
alterations in mechanical force in a PAN model of glomerular injury, 
we hypothesize that podocytes are able to recover from acute damage 
but may remain susceptible to intraglomerular hypertension-induced 
detachment in vivo. By introducing robust and high-throughput me-
chanical phenotyping and by demonstrating the significance of me-
chanical forces in podocyte injury, this research paves the way to a 
new level of understanding in kidney disease. In addition, our work 
represents an integration of cellular force measurements with im-
munofluorescence and of continuous long-term force measurement 
of a cell population, both of which have been unfeasible or impractical 
with established force mapping techniques. Hence, our approach has 
Fig. 5. Mapping podocyte force transmission in a PAN injury model. (A and C) Phase-contrast images (upper rows), ERISM displacement maps (lower rows), and Fourier- 
filtered ERISM maps (lower rows) during (A) PAN treatment and (C) PAN washout of an LY podocyte. Before the measurement, the cell was allowed to differentiate on the 
ERISM microcavity substrate over the course of 12 days. (B and D) Change in exerted cell force (B) and cell area (D) during PAN treatment and PAN washout, continuously 
measured for four different cells. The green trace corresponds to the cell shown in (A) and (C). The purple trace corresponds to a cell that dies at 11.5 hours, presumably 
as a result of the PAN injury. Scale bars, 50 µm.
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general applicability to a wide range of biomedical questions involving 
mechanical forces.
MATERIALS AND METHODS
Cell culture
LY podocytes were obtained as a gift from M. Saleem (Bristol, UK). 
LY podocytes were isolated from a 6-year-old female patient with a 
neuropathic bladder, whose kidney was removed because of infec-
tious complications of the urinary tract but had no evidence of pri-
mary glomerular disease. Primary LY podocytes were immortalized 
via retroviral transduction with the BiCis3 construct, containing 
hTERT and the SV40 temperature-sensitive transgene (28). Prolif-
erating LY podocytes were cultured at the permissive temperature 
of 33°C, 5% CO2 in RPMI supplemented with 10% fetal bovine serum 
(FBS), 1% penicillin-streptomycin (PS), and 1% insulin-transferrin- 
selenium (ITS). LY podocytes were cultured under differentiation 
conditions at 37°C, 5% CO2 for 12 days in RPMI supplemented with 
2% FBS, 1% PS, and 1% ITS. Mouse podocytes (30) were obtained as a 
gift from N. Jones (Guelph, Ontario, Canada) and were cultured at the 
permissive temperature of 33°C, 5% CO2 in Dulbecco’s modified Eagle’s 
medium (DMEM)/F12 supplemented with 10% FBS, 1% PS, and re-
combinant mouse interferon- (IFN-) (10 U/ml). To induce dif-
ferentiation, mouse podocytes were cultured under nonpermissive 
conditions at 37°C, 5% CO2 for 12 days in DMEM/F12 supplemented 
with 2% FBS and 1% PS, in the absence of IFN-. PAN was used as a 
glomerular injury model at a concentration of 25 g/ml for 24 hours. 
PAN washout experiments entailed 2× phosphate-buffered saline (PBS) 
wash and replacement of PAN with fresh differentiation medium for 
5 days. Medium was changed every 2 to 3 days for all experiments.
Scanning electron microscopy
LY podocytes were cultured on No.2 glass coverslips for 12 days at 
37°C, 5% CO2 in RPMI supplemented with 2% FBS, 1% PS, and 1% 
ITS. Fully differentiated cells were washed in PBS and fixed over-
night (>12 hours) at 4°C with 2.5% glutaraldehyde in 0.1 M phos-
phate buffer (pH 7.2). Cells were washed three times for 5 min in 0.1 M 
phosphate buffer (pH 7.2), shaking at 15 rpm. Cells were dehydrated 
in 70, 80, and 90% ethanol for 10 min, respectively, shaking at 15 rpm. 
Cells were washed three times for 10 min in 100% ethanol followed 
by a 10-min wash in hexamethyldisilazane and dried overnight. 
Coverslips were then sputter-coated in gold with a Q150T Turbo- 
Pumped Sputter Coater and imaged with an EVO MA10 scanning 
electron microscope.
Immunocytochemistry
Podocytes were cultured on No.2 glass coverslips in six-well plates or 
directly on ERISM chips, where immunofluorescence was combined 
with force measurements. Cells were washed two times in PBS and 
fixed in 4% paraformaldehyde for 10 min at room temperature. 
Cells were washed for 5 min in PBS and permeabilized in PBS sup-
plemented with 0.2% Triton X-100 for 5 min, shaking at 15 rpm. 
Cells were then blocked with 5% bovine serum albumin (BSA) and 
0.1% Triton X-100 in PBS for 30 min, shaking at 15 rpm. Coverslips 
were incubated overnight at 4°C in primary antibody: nephrin 
rabbit polyclonal antibody (1:200) (Thermo Fisher Scientific, PA5-
20330), CD2AP rabbit polyclonal antibody (1:200) (Sigma- Aldrich, 
HPA003326), podocin mouse polyclonal antibody (1:150) (Abcam, 
ab168625), synaptopodin mouse monoclonal antibody (1:200) 
(Progen Biotechnik, 61094), 1 integrin rabbit polyclonal antibody 
(1:400) (Proteintech, 12594-1-AP), or vinculin mouse monoclonal 
antibody (1:200) (Sigma-Aldrich, FAK100) in 5% BSA, 0.1% Triton 
X-100 in PBS. Following incubation in primary antibody, covers-
lips were washed three times for 5 min in PBS, shaking at 15 rpm. 
Coverslips were incubated in secondary antibody (1:200) Alexa Fluor 
568 goat anti-mouse (Life Technologies, Z25006), Alexa Fluor 568 
goat anti-rabbit (Life Technologies, Z25306), or Alexa Fluor 647 phal-
loidin (Thermo Fisher Scientific, A22287), where indicated, in 3% BSA 
in PBS for 60 min protected from light. Coverslips were then washed 
five times for 5 min in PBS protected from light, shaking at 15 rpm. 
Coverslips were mounted on frosted glass slides with ProLong Gold 
Antifade Reagent with DAPI (Invitrogen, P36931). Slides were imaged 
with a Leica DM5500 B microscope.
Elastic resonator interference stress microscopy
ERISM substrates were fabricated, as described previously (27), and 
a silicon chamber (surface area, 1.60 × 1.60 cm2; Ibid) was applied. 
Substrates were coated with type IV collagen at 4°C overnight (Sigma- 
Aldrich, CC5533), washed two times with PBS, and preincubated at 
33°C, 5% CO2 with fresh RPMI medium supplemented with 10% FBS, 
1% PS, and 1% ITS for 30 min. LY podocytes were then seeded onto 
the ERISM substrate at a density of 500 cells per well. Cells were cul-
tured at the permissive temperature of 33°C, 5% CO2 for 24 hours 
and then transferred to 37°C, 5% CO2 culture conditions in RPMI 
supplemented with 2% FBS, 1% PS, and 1% ITS for 12 days during 
differentiation. Mouse podocytes were seeded on ERISM substrates 
and maintained at the nonpermissive conditions as described above. 
To obtain single-cell measurement for the later stages of differenti-
ation, mouse podocytes were differentiated for 8 days before seeding 
on ERISM substrates. ERISM force measurements were performed 
as described in (27). ERISM maps were recorded on days 1, 5, 8, and 
12 of differentiation (using a 20× microscope objective) (n ≥ 15) and 
continuously (one frame every 30 min for each of the fields of view 
that were tracked) for the duration of PAN treatment and the first 
24 hours of PAN washout (n = 4). To record time-lapse data for 
multiple cells simultaneously, the previously described ERISM con-
figuration was extended by a programmable motorized translation 
stage that facilitated monitoring multiple regions of interest in quick 
succession.
Statistical analysis
The Kolmogorov-Smirnov normality test was used to investigate 
whether data in groups followed Gaussian distribution. As data in 
groups were not normally distributed, groups were compared using 
the Mann-Whitney U test (*P < 0.05; **P < 0.01; ***P < 0.001; ****P < 
0.0001).
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/4/6/eaap8030/DC1
fig. S1. Mapping mechanical force exerted by an LY podocyte layer throughout differentiation.
fig. S2. Differentiation of LY podocytes on ERISM substrate.
fig. S3. Mapping mechanical force exerted by mouse podocytes throughout differentiation.
fig. S4. Differentiation of mouse podocytes.
fig. S5. Contractile podocyte forces are colocalized with vinculin expression.
fig. S6. Mapping force transmission and vinculin expression in a PAN injury model.
fig. S7. Mapping mouse podocyte force transmission in a PAN injury model.
fig. S8. Comparison of LY podocyte force before and after PAN treatment and washout.
video S1. Addition of PAN to differentiated LY podocytes.
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video S2. Washout of PAN-treated, differentiated LY podocytes.
video S3. Addition of PAN to differentiated mouse podocytes.
video S4. Washout of PAN-treated, differentiated mouse podocytes.
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